Craft

Natera

Stock Price

$124.7

2024-10-29

Market Capitalization

$15.4 B

2024-10-29

Revenue

$2.3 B

FY, 2025

Natera Summary

Company Summary

Overview
Natera (formerly known as Gene Security Network) is a diagnostics company with proprietary molecular and bioinformatics technology. It develops a cell-free DNA (cfDNA) testing platform, dedicated to oncology, women’s health, and organ health.
Type
Public
Status
Active
Founded
2004
HQ
Austin, TX, US | view all locations
Website
https://www.natera.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Steve Chapman

    Steve Chapman, Chief Executive Officer and Director

  • Mike Brophy

    Mike Brophy, Chief Financial Officer

  • Robert Schueren

    Robert Schueren, Chief Operating Officer

  • Olesya Anisimova

    Olesya Anisimova, Chief Accounting Officer

Operating MetricsView all

Covered Lives

230M
7.5%

FY, 2021

Tests

489.3K
40.5%

Q1, 2022

Facilities Leased, sq. ft.

272K

FY, 2021

LocationsView all

2 locations detected

  • Austin, TX HQ

    United States

    13011 McCallen Pass a 100

  • San Carlos, CA

    United States

    201 Industrial Rd

Natera Financials

Summary Financials

Revenue (Q1, 2026)
$696.6M
Net income (Q1, 2026)
($85.1M)
Cash (Q1, 2026)
$1.1B
EBIT (Q1, 2026)
($93.5M)
Enterprise value
$14.6B

Footer menu